Oncolytics Biotech Inc.
NASDAQ:ONCY · NASDAQ Capital Market
+$0.03 today
Vol 1.00M · Avg 1.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+50.71%
Period High
$1.42
Period Low
$0.64
Latest
$0.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Immix Biopharma, Inc.
NASDAQ:IMMX
$504.31M
Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
$262.07M
MacroGenics, Inc.
NASDAQ:MGNX
$259.02M
Whitehawk Therapeutics Inc
NASDAQ:WHWK
$214.13M
Surrozen, Inc.
NASDAQ:SRZN
$169.32M
Coya Therapeutics, Inc.
NASDAQ:COYA
$89.04M
Clene Inc.
NASDAQ:CLNN
$61.07M
Instil Bio, Inc.
NASDAQ:TIL
$51.37M
Tevogen Bio Holdings Inc.
TVGN
$43.48M
Atossa Therapeutics, Inc.
ATOS
$17.22M
What is the latest ONCY filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does ONCY have?
Intrinsic Alpha currently shows 20 recent filings for ONCY.
Explore More
Continue the stock analysis
Jump to another research area for this company.